

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.85502528 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79459589 |
| 3 | response to peptidoglycan (GO:0032494) | 3.65241896 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.64264251 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.49335297 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 3.45450850 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 3.45450850 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.45450850 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.45450850 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.45450850 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 3.45450850 |
| 12 | type I interferon signaling pathway (GO:0060337) | 3.45251106 |
| 13 | cellular response to type I interferon (GO:0071357) | 3.45251106 |
| 14 | response to type I interferon (GO:0034340) | 3.40944348 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.35197106 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.27975881 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 3.19381985 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.14357360 |
| 19 | positive regulation of interferon-alpha production (GO:0032727) | 3.12841637 |
| 20 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.12557787 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 3.10572758 |
| 22 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.07732521 |
| 23 | negative regulation of cell killing (GO:0031342) | 3.03051834 |
| 24 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.03051834 |
| 25 | hepatocyte apoptotic process (GO:0097284) | 2.99837116 |
| 26 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.90762074 |
| 27 | nuclear pore complex assembly (GO:0051292) | 2.90258708 |
| 28 | response to interferon-alpha (GO:0035455) | 2.88926176 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 2.86099966 |
| 30 | macrophage activation involved in immune response (GO:0002281) | 2.85877019 |
| 31 | germinal center formation (GO:0002467) | 2.82776913 |
| 32 | mitotic chromosome condensation (GO:0007076) | 2.76171703 |
| 33 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.73397374 |
| 34 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69933322 |
| 35 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.68415439 |
| 36 | necroptotic process (GO:0070266) | 2.68113023 |
| 37 | programmed necrotic cell death (GO:0097300) | 2.65786407 |
| 38 | detection of other organism (GO:0098543) | 2.63317625 |
| 39 | negative regulation of viral genome replication (GO:0045071) | 2.61484962 |
| 40 | detection of molecule of bacterial origin (GO:0032490) | 2.58223830 |
| 41 | positive regulation of interferon-beta production (GO:0032728) | 2.55609269 |
| 42 | granulocyte activation (GO:0036230) | 2.55585905 |
| 43 | leukocyte aggregation (GO:0070486) | 2.53204554 |
| 44 | response to interleukin-15 (GO:0070672) | 2.50972991 |
| 45 | detection of bacterium (GO:0016045) | 2.50674737 |
| 46 | DNA unwinding involved in DNA replication (GO:0006268) | 2.49844515 |
| 47 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.49501149 |
| 48 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.49319035 |
| 49 | neutrophil activation (GO:0042119) | 2.48930173 |
| 50 | B cell mediated immunity (GO:0019724) | 2.48009462 |
| 51 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.47819330 |
| 52 | necrotic cell death (GO:0070265) | 2.45577773 |
| 53 | T cell migration (GO:0072678) | 2.45051231 |
| 54 | response to muramyl dipeptide (GO:0032495) | 2.44610447 |
| 55 | pyrimidine nucleoside salvage (GO:0043097) | 2.43957345 |
| 56 | pyrimidine-containing compound salvage (GO:0008655) | 2.43957345 |
| 57 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.43926712 |
| 58 | Golgi transport vesicle coating (GO:0048200) | 2.42575297 |
| 59 | COPI coating of Golgi vesicle (GO:0048205) | 2.42575297 |
| 60 | pore complex assembly (GO:0046931) | 2.42484101 |
| 61 | response to interferon-beta (GO:0035456) | 2.39931228 |
| 62 | cellular response to virus (GO:0098586) | 2.39427094 |
| 63 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.36554687 |
| 64 | myeloid dendritic cell differentiation (GO:0043011) | 2.35586925 |
| 65 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.35512626 |
| 66 | detection of external biotic stimulus (GO:0098581) | 2.35156529 |
| 67 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.34724832 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 2.34699195 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 2.34521708 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.34238892 |
| 71 | cellular extravasation (GO:0045123) | 2.32900714 |
| 72 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.32520908 |
| 73 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.31830376 |
| 74 | interferon-gamma secretion (GO:0072643) | 2.31551764 |
| 75 | nuclear pore organization (GO:0006999) | 2.31497389 |
| 76 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.31061151 |
| 77 | regulation of necroptotic process (GO:0060544) | 2.30920616 |
| 78 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.29640325 |
| 79 | regulation of superoxide anion generation (GO:0032928) | 2.28119086 |
| 80 | cellular response to interferon-alpha (GO:0035457) | 2.28087232 |
| 81 | regulation of B cell apoptotic process (GO:0002902) | 2.27687073 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.27585469 |
| 83 | response to host (GO:0075136) | 2.27253698 |
| 84 | response to host defenses (GO:0052200) | 2.27253698 |
| 85 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.27253698 |
| 86 | regulation of gamma-delta T cell activation (GO:0046643) | 2.27147557 |
| 87 | regulation of T cell tolerance induction (GO:0002664) | 2.26933729 |
| 88 | gonadal mesoderm development (GO:0007506) | 2.26035306 |
| 89 | response to host immune response (GO:0052572) | 2.25783021 |
| 90 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.25783021 |
| 91 | positive regulation of macrophage differentiation (GO:0045651) | 2.25551885 |
| 92 | regulation of viral genome replication (GO:0045069) | 2.24999422 |
| 93 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.24886684 |
| 94 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.24682140 |
| 95 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.24492697 |
| 96 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.24285705 |
| 97 | mitotic sister chromatid segregation (GO:0000070) | 2.24231485 |
| 98 | pinocytosis (GO:0006907) | 2.23893413 |
| 99 | regulation of mast cell degranulation (GO:0043304) | 2.23182640 |
| 100 | defense response to protozoan (GO:0042832) | 2.22879508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.02752913 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.36874989 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.94297772 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.82599528 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48234886 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.43264358 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.37554636 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.31975189 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.24165617 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19352537 |
| 11 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.14328949 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12799206 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.10767164 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.06641059 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05024849 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03911594 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.01456470 |
| 18 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.01293827 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96797446 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93401616 |
| 21 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.91944579 |
| 22 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.91647792 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89857382 |
| 24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84780008 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.82273771 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 1.80830751 |
| 27 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.79407586 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74880680 |
| 29 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.73185045 |
| 30 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72498144 |
| 31 | * MYB_26560356_Chip-Seq_TH2_Human | 1.67488424 |
| 32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.66820365 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66480033 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65051805 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63804028 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63533347 |
| 37 | * MYB_26560356_Chip-Seq_TH1_Human | 1.59516053 |
| 38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.59408237 |
| 39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56063738 |
| 40 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.53894204 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.53818430 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51561035 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.48984634 |
| 44 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.48666550 |
| 45 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.48502605 |
| 46 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.46900662 |
| 47 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46157402 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46056657 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.45274935 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45119754 |
| 51 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.44274502 |
| 52 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43782368 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42683870 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.39544214 |
| 55 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.37345062 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.37267833 |
| 57 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.35401790 |
| 58 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.34568840 |
| 59 | MAF_26560356_Chip-Seq_TH2_Human | 1.34371597 |
| 60 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29465032 |
| 61 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.27806890 |
| 62 | GATA1_22025678_ChIP-Seq_K562_Human | 1.25283297 |
| 63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23905279 |
| 64 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.20957254 |
| 65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.20698533 |
| 66 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20148082 |
| 67 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.20028227 |
| 68 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.18622797 |
| 69 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17478237 |
| 70 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.17060227 |
| 71 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16777914 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15984511 |
| 73 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.15500981 |
| 74 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.13776777 |
| 75 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13433577 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12143665 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11733477 |
| 78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.11601546 |
| 79 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10940084 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.09979125 |
| 81 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.09464849 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09081442 |
| 83 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.08098569 |
| 84 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08079305 |
| 85 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07724416 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07689131 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07003950 |
| 88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.06896726 |
| 89 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.05877892 |
| 90 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04734657 |
| 91 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03570933 |
| 92 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.03107883 |
| 93 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.02829255 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02318012 |
| 95 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01302206 |
| 96 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.00618212 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00419085 |
| 98 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99824670 |
| 99 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.99243224 |
| 100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98206756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.08684234 |
| 2 | MP0003436_decreased_susceptibility_to | 2.93026903 |
| 3 | MP0003303_peritoneal_inflammation | 2.77344275 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 2.56003093 |
| 5 | MP0005451_abnormal_body_composition | 2.47435057 |
| 6 | MP0000685_abnormal_immune_system | 2.44211956 |
| 7 | MP0009785_altered_susceptibility_to | 2.23786491 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.23596088 |
| 9 | MP0005671_abnormal_response_to | 2.22046402 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 2.19833752 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.19796440 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.17121046 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.15175293 |
| 14 | MP0001800_abnormal_humoral_immune | 2.15155372 |
| 15 | MP0001790_abnormal_immune_system | 2.11293738 |
| 16 | MP0005387_immune_system_phenotype | 2.11293738 |
| 17 | MP0003724_increased_susceptibility_to | 2.08488607 |
| 18 | MP0006082_CNS_inflammation | 2.06185755 |
| 19 | MP0002419_abnormal_innate_immunity | 2.03694190 |
| 20 | MP0002723_abnormal_immune_serum | 2.02832437 |
| 21 | MP0005025_abnormal_response_to | 2.02461154 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.01128748 |
| 23 | MP0003300_gastrointestinal_ulcer | 1.95671051 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.90007864 |
| 25 | MP0002420_abnormal_adaptive_immunity | 1.88495618 |
| 26 | MP0001819_abnormal_immune_cell | 1.87092555 |
| 27 | MP0003806_abnormal_nucleotide_metabolis | 1.84470905 |
| 28 | MP0001853_heart_inflammation | 1.79941351 |
| 29 | MP0002398_abnormal_bone_marrow | 1.79386679 |
| 30 | MP0003111_abnormal_nucleus_morphology | 1.77370010 |
| 31 | MP0002254_reproductive_system_inflammat | 1.75934207 |
| 32 | MP0008057_abnormal_DNA_replication | 1.72992056 |
| 33 | MP0000858_altered_metastatic_potential | 1.70558590 |
| 34 | MP0003693_abnormal_embryo_hatching | 1.67030548 |
| 35 | MP0002405_respiratory_system_inflammati | 1.66388324 |
| 36 | MP0004947_skin_inflammation | 1.65748574 |
| 37 | MP0000716_abnormal_immune_system | 1.60795619 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.58911321 |
| 39 | MP0010094_abnormal_chromosome_stability | 1.56437950 |
| 40 | MP0002722_abnormal_immune_system | 1.54158786 |
| 41 | MP0003172_abnormal_lysosome_physiology | 1.52903213 |
| 42 | MP0008260_abnormal_autophagy | 1.51111064 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.49886635 |
| 44 | MP0002429_abnormal_blood_cell | 1.47393678 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.44188744 |
| 46 | MP0000703_abnormal_thymus_morphology | 1.44135956 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.44124905 |
| 48 | MP0004233_abnormal_muscle_weight | 1.43846623 |
| 49 | MP0002396_abnormal_hematopoietic_system | 1.43772959 |
| 50 | MP0005076_abnormal_cell_differentiation | 1.41446002 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.40682697 |
| 52 | MP0004957_abnormal_blastocyst_morpholog | 1.38489474 |
| 53 | MP0004808_abnormal_hematopoietic_stem | 1.38184127 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.37676916 |
| 55 | MP0002166_altered_tumor_susceptibility | 1.35583905 |
| 56 | MP0001873_stomach_inflammation | 1.34047236 |
| 57 | MP0009840_abnormal_foam_cell | 1.33678229 |
| 58 | MP0003077_abnormal_cell_cycle | 1.33163127 |
| 59 | MP0008469_abnormal_protein_level | 1.26575300 |
| 60 | MP0003656_abnormal_erythrocyte_physiolo | 1.22185223 |
| 61 | MP0002006_tumorigenesis | 1.21969293 |
| 62 | MP0010155_abnormal_intestine_physiology | 1.21377328 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.16040056 |
| 64 | MP0010307_abnormal_tumor_latency | 1.14219957 |
| 65 | MP0009764_decreased_sensitivity_to | 1.14076519 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.13401880 |
| 67 | MP0003091_abnormal_cell_migration | 1.12898897 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 1.09714301 |
| 69 | MP0010352_gastrointestinal_tract_polyps | 1.09600894 |
| 70 | MP0009278_abnormal_bone_marrow | 1.06008977 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.02487842 |
| 72 | MP0003448_altered_tumor_morphology | 1.01478323 |
| 73 | MP0003786_premature_aging | 1.01313204 |
| 74 | MP0008058_abnormal_DNA_repair | 1.01030451 |
| 75 | MP0000490_abnormal_crypts_of | 1.00795729 |
| 76 | MP0000343_altered_response_to | 0.99775515 |
| 77 | MP0005310_abnormal_salivary_gland | 0.98952568 |
| 78 | MP0003075_altered_response_to | 0.94922395 |
| 79 | MP0003828_pulmonary_edema | 0.93587054 |
| 80 | MP0005621_abnormal_cell_physiology | 0.92806620 |
| 81 | MP0000313_abnormal_cell_death | 0.92609820 |
| 82 | MP0004510_myositis | 0.91210324 |
| 83 | MP0005083_abnormal_biliary_tract | 0.89371312 |
| 84 | MP0000350_abnormal_cell_proliferation | 0.89214698 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.89208103 |
| 86 | MP0003453_abnormal_keratinocyte_physiol | 0.85751614 |
| 87 | MP0001545_abnormal_hematopoietic_system | 0.84415096 |
| 88 | MP0005397_hematopoietic_system_phenotyp | 0.84415096 |
| 89 | MP0004185_abnormal_adipocyte_glucose | 0.83842476 |
| 90 | MP0002132_abnormal_respiratory_system | 0.83832779 |
| 91 | MP0000358_abnormal_cell_content/ | 0.83457839 |
| 92 | MP0005164_abnormal_response_to | 0.80937937 |
| 93 | MP0001730_embryonic_growth_arrest | 0.78547072 |
| 94 | MP0005384_cellular_phenotype | 0.76192197 |
| 95 | MP0003705_abnormal_hypodermis_morpholog | 0.75378670 |
| 96 | MP0006054_spinal_hemorrhage | 0.75328384 |
| 97 | MP0000609_abnormal_liver_physiology | 0.74388193 |
| 98 | MP0009763_increased_sensitivity_to | 0.73424560 |
| 99 | MP0006035_abnormal_mitochondrial_morpho | 0.72371910 |
| 100 | MP0003045_fibrosis | 0.71602687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.09587306 |
| 2 | Recurrent abscess formation (HP:0002722) | 3.97915251 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.82052433 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.51414464 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.51414464 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.51414464 |
| 7 | Myositis (HP:0100614) | 3.49143062 |
| 8 | Orchitis (HP:0100796) | 3.46711196 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39026360 |
| 10 | Eczematoid dermatitis (HP:0000976) | 3.28647183 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.23009037 |
| 12 | Optic neuritis (HP:0100653) | 3.23009037 |
| 13 | Recurrent viral infections (HP:0004429) | 3.19593001 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.18900111 |
| 15 | Recurrent fungal infections (HP:0002841) | 3.02993024 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 2.97353131 |
| 17 | Recurrent cutaneous fungal infections (HP:0011370) | 2.88544073 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.88544073 |
| 19 | Obstructive lung disease (HP:0006536) | 2.85234839 |
| 20 | Chronic obstructive pulmonary disease (HP:0006510) | 2.85234839 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 2.79985207 |
| 22 | Fatigue (HP:0012378) | 2.74388120 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 2.72115868 |
| 24 | Increased IgM level (HP:0003496) | 2.68553018 |
| 25 | Meningitis (HP:0001287) | 2.67986465 |
| 26 | Recurrent skin infections (HP:0001581) | 2.67509553 |
| 27 | Hypertensive crisis (HP:0100735) | 2.60183135 |
| 28 | Abnormality of T cell physiology (HP:0011840) | 2.58496058 |
| 29 | Encephalitis (HP:0002383) | 2.56219899 |
| 30 | Autoimmune hemolytic anemia (HP:0001890) | 2.54990600 |
| 31 | Stomatitis (HP:0010280) | 2.53712677 |
| 32 | T lymphocytopenia (HP:0005403) | 2.52981847 |
| 33 | Vasculitis (HP:0002633) | 2.48844688 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.47553557 |
| 35 | Abnormality of T cells (HP:0002843) | 2.44552915 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.38547191 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.32795404 |
| 38 | Petechiae (HP:0000967) | 2.29319759 |
| 39 | Pustule (HP:0200039) | 2.26427908 |
| 40 | Cellulitis (HP:0100658) | 2.26109112 |
| 41 | Urticaria (HP:0001025) | 2.25981740 |
| 42 | Entropion (HP:0000621) | 2.25597364 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.24905667 |
| 44 | Vertebral compression fractures (HP:0002953) | 2.23834106 |
| 45 | Colitis (HP:0002583) | 2.22145218 |
| 46 | Myocardial infarction (HP:0001658) | 2.21833394 |
| 47 | Viral hepatitis (HP:0006562) | 2.21532730 |
| 48 | Increased cerebral lipofuscin (HP:0011813) | 2.17507161 |
| 49 | Anorexia (HP:0002039) | 2.16622658 |
| 50 | Keratoconjunctivitis sicca (HP:0001097) | 2.14694413 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.14588054 |
| 52 | Arterial thrombosis (HP:0004420) | 2.14029105 |
| 53 | Increased serum ferritin (HP:0003281) | 2.11186079 |
| 54 | Rough bone trabeculation (HP:0100670) | 2.09246446 |
| 55 | Granulocytopenia (HP:0001913) | 2.07964069 |
| 56 | Orthostatic hypotension (HP:0001278) | 2.06620945 |
| 57 | Cholecystitis (HP:0001082) | 2.05972884 |
| 58 | Abnormal gallbladder physiology (HP:0012438) | 2.05972884 |
| 59 | Poikiloderma (HP:0001029) | 2.03447446 |
| 60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.03395011 |
| 61 | Gastrointestinal inflammation (HP:0004386) | 2.02806307 |
| 62 | Micronodular cirrhosis (HP:0001413) | 2.02083658 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.01539116 |
| 64 | Slow saccadic eye movements (HP:0000514) | 2.01284266 |
| 65 | Keratoconjunctivitis (HP:0001096) | 1.99678879 |
| 66 | Glomerulopathy (HP:0100820) | 1.99344052 |
| 67 | Inflammation of the large intestine (HP:0002037) | 1.98395086 |
| 68 | Acute hepatic failure (HP:0006554) | 1.98370509 |
| 69 | Thrombocytosis (HP:0001894) | 1.97427896 |
| 70 | IgA deficiency (HP:0002720) | 1.96738293 |
| 71 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96589826 |
| 72 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96589826 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96589826 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96365631 |
| 75 | Lymphopenia (HP:0001888) | 1.95561883 |
| 76 | Subacute progressive viral hepatitis (HP:0006572) | 1.95076040 |
| 77 | Squamous cell carcinoma (HP:0002860) | 1.93950688 |
| 78 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.93635585 |
| 79 | Nonimmune hydrops fetalis (HP:0001790) | 1.93529388 |
| 80 | Hypergammaglobulinemia (HP:0010702) | 1.92712519 |
| 81 | Progressive neurologic deterioration (HP:0002344) | 1.90834228 |
| 82 | Chest pain (HP:0100749) | 1.90804131 |
| 83 | Abnormality of the pericardium (HP:0001697) | 1.88984800 |
| 84 | Mucopolysacchariduria (HP:0008155) | 1.87513432 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.87513432 |
| 86 | Hepatosplenomegaly (HP:0001433) | 1.86832164 |
| 87 | Cutaneous melanoma (HP:0012056) | 1.85120616 |
| 88 | Lymphoma (HP:0002665) | 1.84944306 |
| 89 | Hypokinesia (HP:0002375) | 1.84344206 |
| 90 | Abnormality of oral frenula (HP:0000190) | 1.82690993 |
| 91 | Abnormality of the peritoneum (HP:0002585) | 1.80966334 |
| 92 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.80282364 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78209734 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.77751944 |
| 95 | Gastrointestinal stroma tumor (HP:0100723) | 1.77272233 |
| 96 | Osteomyelitis (HP:0002754) | 1.75694737 |
| 97 | Amaurosis fugax (HP:0100576) | 1.74912979 |
| 98 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.74394746 |
| 99 | Epistaxis (HP:0000421) | 1.73506661 |
| 100 | Abnormal trabecular bone morphology (HP:0100671) | 1.71888022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.42123760 |
| 2 | PRPF4B | 2.79367554 |
| 3 | TESK2 | 2.77607753 |
| 4 | RIPK4 | 2.36768620 |
| 5 | ERN1 | 2.35388126 |
| 6 | IRAK4 | 2.32345369 |
| 7 | MAP4K1 | 2.31800312 |
| 8 | NME2 | 2.30345434 |
| 9 | MAP3K14 | 2.30054746 |
| 10 | TYK2 | 2.27985655 |
| 11 | SMG1 | 2.27884743 |
| 12 | BUB1 | 2.14645065 |
| 13 | MAP2K3 | 2.09389718 |
| 14 | STK10 | 1.95239409 |
| 15 | TAOK2 | 1.84873351 |
| 16 | MAP3K3 | 1.78826315 |
| 17 | SIK3 | 1.71790528 |
| 18 | TBK1 | 1.69015267 |
| 19 | JAK3 | 1.67750547 |
| 20 | TRIB3 | 1.61067038 |
| 21 | BLK | 1.56695573 |
| 22 | ICK | 1.46653933 |
| 23 | ZAP70 | 1.43041271 |
| 24 | IKBKE | 1.41008230 |
| 25 | KSR2 | 1.39514546 |
| 26 | MAP3K8 | 1.38366931 |
| 27 | PAK4 | 1.36513047 |
| 28 | CDK12 | 1.35416582 |
| 29 | CLK1 | 1.27190970 |
| 30 | EIF2AK1 | 1.25625872 |
| 31 | CSK | 1.22844569 |
| 32 | BMPR2 | 1.16624971 |
| 33 | MAP3K13 | 1.09538179 |
| 34 | PBK | 1.08349554 |
| 35 | MARK3 | 1.07907079 |
| 36 | IKBKB | 1.06688758 |
| 37 | VRK2 | 1.03359944 |
| 38 | EPHB1 | 1.02610118 |
| 39 | EPHA2 | 1.00218039 |
| 40 | JAK1 | 0.98603508 |
| 41 | MELK | 0.97055598 |
| 42 | MST1R | 0.96757127 |
| 43 | CDK8 | 0.90685164 |
| 44 | BTK | 0.89935020 |
| 45 | MAP3K1 | 0.86258977 |
| 46 | WEE1 | 0.85283714 |
| 47 | GRK6 | 0.84977986 |
| 48 | STK4 | 0.83921636 |
| 49 | MAP3K11 | 0.83501581 |
| 50 | SCYL2 | 0.82219733 |
| 51 | CCNB1 | 0.81193224 |
| 52 | HCK | 0.80526103 |
| 53 | FGR | 0.79816877 |
| 54 | MAP3K2 | 0.78216170 |
| 55 | TESK1 | 0.78206779 |
| 56 | MST4 | 0.77728079 |
| 57 | IRAK1 | 0.77264302 |
| 58 | RAF1 | 0.76561844 |
| 59 | IRAK2 | 0.76168409 |
| 60 | SYK | 0.74848797 |
| 61 | TXK | 0.73447571 |
| 62 | JAK2 | 0.73115292 |
| 63 | MAPK11 | 0.72349720 |
| 64 | TTK | 0.71857732 |
| 65 | CHEK2 | 0.71402245 |
| 66 | EEF2K | 0.70073008 |
| 67 | TGFBR2 | 0.67896291 |
| 68 | CDK7 | 0.67537071 |
| 69 | GRK7 | 0.67274931 |
| 70 | MOS | 0.67136243 |
| 71 | MAP3K5 | 0.67001276 |
| 72 | LRRK2 | 0.66422842 |
| 73 | CSF1R | 0.65130895 |
| 74 | RPS6KB2 | 0.64805281 |
| 75 | CDK4 | 0.64401496 |
| 76 | YES1 | 0.62823006 |
| 77 | MAP3K10 | 0.62228513 |
| 78 | KSR1 | 0.61766470 |
| 79 | BRAF | 0.60713420 |
| 80 | SRPK1 | 0.60683463 |
| 81 | SIK1 | 0.60069469 |
| 82 | FGFR4 | 0.60043754 |
| 83 | PIM1 | 0.59177093 |
| 84 | BRSK1 | 0.59112664 |
| 85 | ARAF | 0.58199668 |
| 86 | CDC7 | 0.57206100 |
| 87 | LCK | 0.56867145 |
| 88 | LYN | 0.54759055 |
| 89 | EIF2AK3 | 0.52941510 |
| 90 | TAF1 | 0.51409292 |
| 91 | BMX | 0.50489840 |
| 92 | PDK1 | 0.50416352 |
| 93 | NEK9 | 0.49962974 |
| 94 | PDPK1 | 0.49913325 |
| 95 | TAOK1 | 0.49864021 |
| 96 | MAPKAPK2 | 0.49337763 |
| 97 | PAK1 | 0.46459766 |
| 98 | MAP3K12 | 0.44517873 |
| 99 | EIF2AK2 | 0.44397328 |
| 100 | CDK9 | 0.43737082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.05525714 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.05018865 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.04936667 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.04252094 |
| 5 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02498776 |
| 6 | Measles_Homo sapiens_hsa05162 | 2.02253646 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.97972561 |
| 8 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94113108 |
| 9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.89818143 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 1.84194160 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 1.82978082 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.77789349 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77498939 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74857815 |
| 15 | Influenza A_Homo sapiens_hsa05164 | 1.69352010 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.66577057 |
| 17 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.63647228 |
| 18 | Shigellosis_Homo sapiens_hsa05131 | 1.62545275 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.60902246 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.54975183 |
| 21 | Hepatitis B_Homo sapiens_hsa05161 | 1.54427034 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52827767 |
| 23 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.51529353 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.47138523 |
| 25 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46322214 |
| 26 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.44611472 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.41929868 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.41435958 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.41377040 |
| 30 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.37641844 |
| 31 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.36220103 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36030172 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35909833 |
| 34 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33105038 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33021339 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29459024 |
| 37 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26296618 |
| 38 | Hepatitis C_Homo sapiens_hsa05160 | 1.26133085 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.25210968 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.23519276 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 1.22196471 |
| 42 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.17304693 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16526259 |
| 44 | Bladder cancer_Homo sapiens_hsa05219 | 1.15750999 |
| 45 | Malaria_Homo sapiens_hsa05144 | 1.15370213 |
| 46 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.11532778 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09263637 |
| 48 | Cell cycle_Homo sapiens_hsa04110 | 1.07969236 |
| 49 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06655397 |
| 50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05906558 |
| 51 | Lysosome_Homo sapiens_hsa04142 | 1.04986928 |
| 52 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.03081273 |
| 53 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.01494003 |
| 54 | Homologous recombination_Homo sapiens_hsa03440 | 1.01203558 |
| 55 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00300806 |
| 56 | Salmonella infection_Homo sapiens_hsa05132 | 1.00074749 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99126557 |
| 58 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.98710029 |
| 59 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.98220898 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97444707 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95841131 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94766541 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 0.94390786 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92241110 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.91998766 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91164011 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88836040 |
| 68 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88540214 |
| 69 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88389837 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86912202 |
| 71 | Phagosome_Homo sapiens_hsa04145 | 0.86898347 |
| 72 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81911579 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78489370 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78480835 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77463598 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.77339097 |
| 77 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77048124 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.76562621 |
| 79 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.76077711 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.68677762 |
| 81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.66718821 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65389734 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64192332 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64031562 |
| 85 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62659983 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.61509105 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59348849 |
| 88 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.59126779 |
| 89 | Prostate cancer_Homo sapiens_hsa05215 | 0.58840715 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.58481841 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57704426 |
| 92 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57316893 |
| 93 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55510660 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54520351 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.53913174 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.52571799 |
| 97 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51302569 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50058634 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48112495 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43892646 |

